Treatment of Progressive MS: Why, Who, When, How
Giancarlo Comi, MD
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Prof. Ralf Gold
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Multiple Sclerosis Physician Resources
Immunologic Effects on Metabolic Syndrome and MS
Optimizing MS Treatment Options
Establishing Partnerships to Optimize Patient Outcomes
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Determining an MS Patient's Long-Term Prognosis
Current and Future MS Treatment Options
The Value of Biomarkers in MS Patients
Current Landscape of MS Diagnosis/Prognosis
Emerging MRI Techniques in MS Patients
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.